{
    "Rank": 806,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT00398281",
                "NCTIdAliasList": {
                    "NCTIdAlias": [
                        "NCT00330057"
                    ]
                },
                "OrgStudyIdInfo": {
                    "OrgStudyId": "CDR0000513051"
                },
                "SecondaryIdInfoList": {
                    "SecondaryIdInfo": [
                        {
                            "SecondaryId": "TJUH-06F-145"
                        }
                    ]
                },
                "Organization": {
                    "OrgFullName": "National Cancer Institute (NCI)",
                    "OrgClass": "NIH"
                },
                "BriefTitle": "Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer",
                "OfficialTitle": "Detection of Prostate Cancer With Contrast-Enhanced Ultrasound After Treatment With Dutasteride"
            },
            "StatusModule": {
                "StatusVerifiedDate": "June 2009",
                "OverallStatus": "Completed",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "November 2006"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "July 2010",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "September 2012",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "November 9, 2006",
                "StudyFirstSubmitQCDate": "November 9, 2006",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "November 10, 2006",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "January 9, 2014",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "January 10, 2014",
                    "LastUpdatePostDateType": "Estimate"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyOldNameTitle": "Ethan J. Halpern",
                    "ResponsiblePartyOldOrganization": "Kimmel Cancer Center at Thomas Jefferson University - Philadelphia"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Sidney Kimmel Cancer Center at Thomas Jefferson University",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "National Cancer Institute (NCI)",
                            "CollaboratorClass": "NIH"
                        }
                    ]
                }
            },
            "DescriptionModule": {
                "BriefSummary": "RATIONALE: Diagnostic procedures, such as ultrasound-guided biopsy, may help find prostate cancer. Dutasteride may improve the ability of ultrasound-guided biopsy to find prostate cancer. It is not yet known whether dutasteride followed by ultrasound-guided biopsy is more effective than a placebo followed by ultrasound-guided biopsy in finding prostate cancer.\n\nPURPOSE: This randomized phase III trial is studying dutasteride and ultrasound-guided biopsy to see how well they find prostate cancer compared with a placebo and ultrasound-guided biopsy.",
                "DetailedDescription": "OBJECTIVES:\n\nDetermine the efficacy of dutasteride followed by contrast-enhanced, ultrasound-guided targeted biopsy in detecting prostate cancer.\nDetermine the detection rate of prostate cancer with targeted biopsy using contrast-enhanced ultrasound combined with dutasteride.\nDetermine the efficacy of targeted biopsy using contrast-enhanced ultrasound vs systematic biopsy in diagnosing clinically significant prostate cancer.\nDetermine the reduction in post-biopsy bleeding after dutasteride in these patients.\nDetermine the cost effectiveness of this regimen in these patients.\n\nOUTLINE: This is a prospective, double-blind, placebo-controlled, randomized study. Patients are randomized to 1 of 2 arms.\n\nArm I: Patients receive oral dutasteride once daily on days 1-14.\nArm II: Patients receive oral placebo once daily on days 1-14. On day 14, patients in both arms undergo blood collection and contrast-enhanced (perflutren protein-type A microspheres) transrectal ultrasound. Conventional gray-scale imaging, color Doppler imaging, and power Doppler imaging are performed. Biopsies are then performed; first up to 6 targeted ultrasound-guided biopsies and then up to 12 systematic biopsies.\n\nAfter completion of study procedures, patients are followed at 1 day.\n\nPROJECTED ACCRUAL: A total of 450 patients will be accrued for this study."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Prostate Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "prostate cancer"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Interventional",
                "PhaseList": {
                    "Phase": [
                        "Phase 3"
                    ]
                },
                "DesignInfo": {
                    "DesignAllocation": "Randomized",
                    "DesignPrimaryPurpose": "Diagnostic",
                    "DesignMaskingInfo": {
                        "DesignMasking": "Double"
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "450",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Arm I",
                            "ArmGroupType": "Experimental",
                            "ArmGroupDescription": "Patients receive oral dutasteride once daily on days 1-14.",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Drug: dutasteride"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "Arm II",
                            "ArmGroupType": "Placebo Comparator",
                            "ArmGroupDescription": "Patients receive oral placebo once daily on days 1-14.",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Other: placebo"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Drug",
                            "InterventionName": "dutasteride",
                            "InterventionDescription": "Given orally",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Arm I"
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "placebo",
                            "InterventionDescription": "Given orally",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Arm II"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Efficacy of short-term dutasteride in improving prostate cancer detection"
                        },
                        {
                            "PrimaryOutcomeMeasure": "Detection rate of prostate cancer"
                        },
                        {
                            "PrimaryOutcomeMeasure": "Cost effectiveness of contrast-enhanced ultrasound"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "DISEASE CHARACTERISTICS:\n\nSuspected prostate cancer due to 1 of the following criteria:\n\nPrior abnormal digital rectal exam\nElevated prostate-specific antigen (PSA) \u2265 2.6 ng/mL within the past 90 days\nPSA velocity > 0.75 ng/mL/year\nMust be planning to undergo a transrectal ultrasound with biopsy\n\nPATIENT CHARACTERISTICS:\n\nMust be in adequate physical health to tolerate a prolonged transrectal examination and biopsy\nMust not be clinically unstable, severely ill, or moribund\n\nPRIOR CONCURRENT THERAPY:\n\nMore than 30 days since prior biopsy of the prostate\nMore than 1 week since prior acetylsalicylic acid or blood thinner\nMore than 30 days since prior participation in a clinical trial involving an investigational drug\nNo prior therapy for prostate cancer\nNo other concurrent 5-alpha reductase inhibitor",
                "HealthyVolunteers": "No",
                "Gender": "Male",
                "MinimumAge": "18 Years",
                "MaximumAge": "80 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                }
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Ethan J. Halpern, MD",
                            "OverallOfficialAffiliation": "Sidney Kimmel Cancer Center at Thomas Jefferson University",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Kimmel Cancer Center at Thomas Jefferson University - Philadelphia",
                            "LocationCity": "Philadelphia",
                            "LocationState": "Pennsylvania",
                            "LocationZip": "19107-5541",
                            "LocationCountry": "United States"
                        }
                    ]
                }
            },
            "ReferencesModule": {
                "ReferenceList": {
                    "Reference": [
                        {
                            "ReferencePMID": "22998915",
                            "ReferenceType": "derived",
                            "ReferenceCitation": "Halpern EJ, Gomella LG, Forsberg F, McCue PA, Trabulsi EJ. Contrast enhanced transrectal ultrasound for the detection of prostate cancer: a randomized, double-blind trial of dutasteride pretreatment. J Urol. 2012 Nov;188(5):1739-45. doi: 10.1016/j.juro.2012.07.021. Epub 2012 Sep 19."
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000011471",
                            "ConditionMeshTerm": "Prostatic Neoplasms"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000005834",
                            "ConditionAncestorTerm": "Genital Neoplasms, Male"
                        },
                        {
                            "ConditionAncestorId": "D000014565",
                            "ConditionAncestorTerm": "Urogenital Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000005832",
                            "ConditionAncestorTerm": "Genital Diseases, Male"
                        },
                        {
                            "ConditionAncestorId": "D000091662",
                            "ConditionAncestorTerm": "Genital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000091642",
                            "ConditionAncestorTerm": "Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000011469",
                            "ConditionAncestorTerm": "Prostatic Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000052801",
                            "ConditionAncestorTerm": "Male Urogenital Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M14025",
                            "ConditionBrowseLeafName": "Prostatic Neoplasms",
                            "ConditionBrowseLeafAsFound": "Prostate Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M8636",
                            "ConditionBrowseLeafName": "Genital Neoplasms, Male",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17005",
                            "ConditionBrowseLeafName": "Urogenital Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2877",
                            "ConditionBrowseLeafName": "Genital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8634",
                            "ConditionBrowseLeafName": "Genital Diseases, Male",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2876",
                            "ConditionBrowseLeafName": "Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14023",
                            "ConditionBrowseLeafName": "Prostatic Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M26785",
                            "ConditionBrowseLeafName": "Male Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BXS",
                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            },
            "InterventionBrowseModule": {
                "InterventionMeshList": {
                    "InterventionMesh": [
                        {
                            "InterventionMeshId": "D000068538",
                            "InterventionMeshTerm": "Dutasteride"
                        }
                    ]
                },
                "InterventionAncestorList": {
                    "InterventionAncestor": [
                        {
                            "InterventionAncestorId": "D000058891",
                            "InterventionAncestorTerm": "5-alpha Reductase Inhibitors"
                        },
                        {
                            "InterventionAncestorId": "D000065088",
                            "InterventionAncestorTerm": "Steroid Synthesis Inhibitors"
                        },
                        {
                            "InterventionAncestorId": "D000004791",
                            "InterventionAncestorTerm": "Enzyme Inhibitors"
                        },
                        {
                            "InterventionAncestorId": "D000045504",
                            "InterventionAncestorTerm": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "InterventionAncestorId": "D000006727",
                            "InterventionAncestorTerm": "Hormone Antagonists"
                        },
                        {
                            "InterventionAncestorId": "D000006730",
                            "InterventionAncestorTerm": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                        },
                        {
                            "InterventionAncestorId": "D000045505",
                            "InterventionAncestorTerm": "Physiological Effects of Drugs"
                        }
                    ]
                },
                "InterventionBrowseLeafList": {
                    "InterventionBrowseLeaf": [
                        {
                            "InterventionBrowseLeafId": "M270",
                            "InterventionBrowseLeafName": "Dutasteride",
                            "InterventionBrowseLeafAsFound": "Orthosis",
                            "InterventionBrowseLeafRelevance": "high"
                        },
                        {
                            "InterventionBrowseLeafId": "M28964",
                            "InterventionBrowseLeafName": "5-alpha Reductase Inhibitors",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M7641",
                            "InterventionBrowseLeafName": "Enzyme Inhibitors",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M9479",
                            "InterventionBrowseLeafName": "Hormones",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M9478",
                            "InterventionBrowseLeafName": "Hormone Antagonists",
                            "InterventionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "InterventionBrowseBranchList": {
                    "InterventionBrowseBranch": [
                        {
                            "InterventionBrowseBranchAbbrev": "All",
                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                        }
                    ]
                }
            }
        }
    }
}